Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05543200 · ClinicalTrials.gov registry record
BPH Global Registry
A clinical trial of Benign Prostatic Hyperplasia and Lower Urinary Tract Symptoms, sponsored by Société Internationale d'Urologie.
- Recruiting
- Registry status
- 7,500
- Enrollment target
- 20
- Study locations
NCT05543200: Recruiting study of Benign Prostatic Hyperplasia and Lower Urinary Tract Symptoms, sponsored by Société Internationale d'Urologie.
NCT05543200 is a study of Benign Prostatic Hyperplasia and Lower Urinary Tract Symptoms that is actively recruiting participants, run by Société Internationale d'Urologie. The registered enrollment target is 7,500 participants, above the 293-participant average among 29 other Benign Prostatic Hyperplasia trials with a reported enrollment target (2460% higher). The trial reports 20 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05543200, a study of Benign Prostatic Hyperplasia and Lower Urinary Tract Symptoms, is actively recruiting participants, sponsored by Société Internationale d'Urologie.
- RECRUITING
- Registry status
- 7,500 participants
- Enrollment target
- 20
- Study locations
Study Summary
Benign prostatic hyperplasia (BPH) is one of the most common performed surgical procedures in urology. Over the past few decades there have been an increasing development of newer surgical treatment options. Additionally, the outcome parameters for BPH treatments have been standardized. While data are available for the initial pivotal studies, post-market release data are lacking. Under the umbrella of uCARE, we have started a prospective, ongoing international registry for recording demographics and outcomes for patients undergoing surgical treatments for BPH.
Primary Outcome
Comparison of mean IPSS score change between baseline and at each follow-up during the course of the study. The scale goes from 0 (Mild) to 35 (Severe).
Conditions Studied
Study Locations (20)
Other
- Hospital Dr. Juan Morey La Unión - La Unión
- Hospital del Trabajador - Santiago
- The First Affiliated Hospital, Zhejiang University School of Medicine - Hangzhou
- University of Cyprus - Nicosia
- Shariati Hospital - Tehran
- University of Basrah - Basra
- Azienda Ospedaliero-Universitaria Careggi - Florence
- Sapienza University of Rome, Division of Urology, Ospedale Sant'Andrea - Rome
- American University of Beirut - Beirut
- Universiti Malaya - Kuala Lumpur
- Kati University Hospital - Kati
- Centro Medico Nacional Siglo XXI - Mexico City
- Benue State University Teaching Hospital, Department of Surgery - Makurdi
- Ahmadu Bello University Teaching Hospital - Zaria
- Institute of Kidney Diseases Peshawar - Peshawar
- Lady Reading Hospital - Peshawar
- Hamad Medical Corporation Qatar - Doha
California
- Keck Medicine of USC - Los Angeles
Ontario
- Toronto Western Hospital, University Health Network - Toronto
Quebec
- McGill University Health Centre - Montreal
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7,500 participants |
| Start Date | 2023-03-13 |
| Est. Completion | 2027-03 |
What NCT05543200 shows while recruiting
NCT05543200 is an observational study that tracks outcomes without assigning an intervention. Its 7,500 participants enrollment target places it among the larger protocols in the corpus, above the 293-participant average among 29 other Benign Prostatic Hyperplasia trials with a reported enrollment target (2460% higher).
The record links to 2 conditions, with Benign Prostatic Hyperplasia appearing as the primary indexed condition, and to 0 interventions.
NCT05543200 names 20 study sites across 4 states, led by Other, California, Ontario.
Frequently Asked Questions
What is clinical trial NCT05543200 about?
NCT05543200 is a clinical study titled "BPH Global Registry". Benign prostatic hyperplasia (BPH) is one of the most common performed surgical procedures in urology. Over the past few decades there have been an increasing development of newer surgical treatment options. Additionally, the outcome parameters for BPH treatments have been standardized. While data a...
What is the current status of trial NCT05543200?
This trial is currently recruiting. The enrollment target is 7,500 participants. The study started on 2023-03-13. Estimated completion is 2027-03.
What conditions does trial NCT05543200 study?
This clinical trial studies the following conditions: Benign Prostatic Hyperplasia, Lower Urinary Tract Symptoms.
Who is sponsoring clinical trial NCT05543200?
This trial is sponsored by Société Internationale d'Urologie, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05543200 being conducted?
This trial has 20 study locations across California, Ontario, Quebec. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Benign Prostatic Hyperplasia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05543200's enrollment target sits among peer trials
7,500 1st of 29 higher than 29 of 29 other Benign Prostatic Hyperplasia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Benign Prostatic Hyperplasia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Customized TULSA-PRO Ablation Registry
RECRUITING
-
OPtilume™ BPH Catheter SystEm for Treatment of Men eXperiencing Symptomatic BPH
RECRUITING
-
Ambulatory Long Length URodynamics Evaluation
RECRUITING · NA
-
Safety and Effectiveness of the Optilume® BPH Catheter System in a Post-Market Study
RECRUITING · NA
-
Sacral Neuromodulation for Male Overactive Bladder (MOAB)
RECRUITING · NA
-
A Clinical Study to Evaluate the Safety and Efficacy of the FloStent in Men With Benign Prostatic Hyperplasia Symptoms
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00439049 · 7,500 participants
Substance Abuse Pre-Treatment Screening Study
- NCT04809740 · 7,500 participants · NA
Evaluating the Implementation and Impact of Navigator-delivered ePRO System
- NCT05199701 · 7,500 participants · NA
Prospective Case Collection Study for New Mammography Technologies
- NCT06112418 · 7,500 participants · NA
A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI